OrbiMed’s Bausch Health BHC Stock Holding History

OrbiMed’s Portfolio BHC Stock Details BHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,399,880	Closed	-$37.2M	–	140
2020 Q1	$37.2M	Sell	2,399,880 -783,220	-25%	-$18.9M	0.63%	46
2019 Q4	$95.2M	Sell	3,183,100 -129,200	-4%	-$3.36M	1.36%	27
2019 Q3	$72.4M	Sell	3,312,300 -428,400	-11%	-$9.8M	1.37%	24
2019 Q2	$94.3M	Hold	3,740,700	–	–	1.46%	18
2019 Q1	$92.4M	Buy	3,740,700 +140,400	+4%	+$3.35M	1.43%	19
2018 Q4	$66.5M	Buy	3,600,300 +1,696,400	+89%	+$40.4M	1.23%	26
2018 Q3	$48.9M	Buy	+1,903,900	New	+$43.6M	0.59%	52
2018 Q1	–	Sell	-76,800	Closed	-$1.6M	–	142
2017 Q4	$1.6M	Sell	76,800 -118,100	-61%	-$1.87M	0.02%	125
2017 Q3	$2.79M	Hold	194,900	–	–	0.03%	128
2017 Q2	$3.37M	Hold	194,900	–	–	0.04%	124
2017 Q1	$2.15M	Hold	194,900	–	–	0.02%	126
2016 Q4	$2.83M	Hold	194,900	–	–	0.04%	118
2016 Q3	$4.79M	Hold	194,900	–	–	0.05%	119
2016 Q2	$3.92M	Hold	194,900	–	–	0.04%	114
2016 Q1	$5.13M	Sell	194,900 -195,100	-50%	-$14.4M	0.05%	116
2015 Q4	$39.6M	Buy	390,000 +225,000	+136%	+$25.3M	0.36%	58
2015 Q3	$29.4M	Hold	165,000	–	–	0.3%	61
2015 Q2	$36.7M	Buy	165,000 +3,000	+2%	+$665K	0.31%	63
2015 Q1	$32.2M	Hold	162,000	–	–	0.27%	66
2014 Q4	$23.2M	Buy	162,000 +24,000	+17%	+$3.23M	0.22%	70
2014 Q3	$18.1M	Hold	138,000	–	–	0.19%	79
2014 Q2	$17.4M	Buy	138,000 +5,000	+4%	+$638K	0.2%	68
2014 Q1	$17.5M	Sell	133,000 -24,000	-15%	-$3.28M	0.22%	69
2013 Q4	$18.4M	Buy	157,000 +19,000	+14%	+$2.08M	0.27%	67
2013 Q3	$14.4M	Hold	138,000	–	–	0.26%	64
2013 Q2	$11.9M	Buy	+138,000	New	+$10.9M	0.25%	70

Other funds holding BHC

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Fidelity International

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

ValueAct Holdings San Francisco, California $5.71B AUM 7.41% 1-Year Est. Return

Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return